Despite advances in antiretroviral therapy (ART), a notable proportion of individuals still present with advanced HIV disease (AHD) at treatment initiation, defined by CD4 < 200 cells/μL or WHO stage 3/4. This evidence concerns the gene CD4 and mitochondrial DNA depletion syndrome 4a.